Search Results - "Feneley, Mark"

Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non–muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial by Tan, Wei Shen, Panchal, Anesh, Buckley, Laura, Devall, Adam J., Loubière, Laurence S., Pope, Ann M., Feneley, Mark R., Cresswell, Jo, Issa, Rami, Mostafid, Hugh, Madaan, Sanjeev, Bhatt, Rupesh, McGrath, John, Sangar, Vijay, Griffiths, T.R. Leyshon, Page, Toby, Hodgson, Dominic, Datta, Shibendra N., Billingham, Lucinda J., Kelly, John D.

“…There is no effective intravesical second-line therapy for non–muscle-invasive bladder cancer (NMIBC) when bacillus Calmette-Guérin (BCG) fails. To compare…”
Get full text

Is Testosterone Treatment Good for the Prostate? Study of Safety during Long‐Term Treatment by Feneley, Mark R., Carruthers, Malcolm

“…For men with androgen deficiency on testosterone replacement therapy (TRT), clinical concern relates to the development of prostate cancer (PCa). An updated…”
Get full text

Quantitative analysis of BTF3, HINT1, NDRG1 and ODC1 protein over-expression in human prostate cancer tissue by Symes, Andrew J, Eilertsen, Marte, Millar, Michael, Nariculam, Joseph, Freeman, Alex, Notara, Maria, Feneley, Mark R, Patel, Hitendra R H, Patel, Hitenedra R H, Masters, John R W, Ahmed, Aamir

“…Prostate carcinoma is the most common cancer in men with few, quantifiable, biomarkers. Prostate cancer biomarker discovery has been hampered due to subjective…”
Get full text

Evolution of testosterone treatment over 25 years: symptom responses, endocrine profiles and cardiovascular changes by Carruthers, Malcolm, Cathcart, Paul, Feneley, Mark R

“…Testosterone treatment has evolved rapidly over the past 25 years as new, more effective and convenient methods have become available. This study reports…”
Get more information

Prostate cancer: diagnosis and staging by Borley, Nigel, Feneley, Mark R

“…Prostate cancer represents an increasing health burden. The past 20 years, with the introduction of prostate-specific antigen (PSA), has seen prostate cancer…”
Get full text

Correction: Quantitative Analysis of BTF3, HINT1, NDRG1 and ODC1 Protein Over-Expression in Human Prostate Cancer Tissue by Symes, Andrew J., Eilertsen, Marte, Millar, Michael, Nariculam, Joseph, Freeman, Alex, Notara, Maria, Feneley, Mark R., Patel, Hitendra R. H., Masters, John R. W., Ahmed, Aamir

Get full text

Plexin-B1 mutations in prostate cancer by Wong, Oscar Gee-Wan, Nitkunan, Tharani, Oinuma, Izumi, Zhou, Chun, Blanc, Veronique, Brown, Richard S.D, Bott, Simon R.J, Nariculam, Joseph, Box, Gary, Munson, Phillipa, Constantinou, Jason, Feneley, Mark R, Klocker, Helmut, Eccles, Suzanne A, Negishi, Manabu, Freeman, Alex, Masters, John R, Williamson, Magali

“…Semaphorins are a large class of secreted or membrane-associated proteins that act as chemotactic cues for cell movement via their transmembrane receptors,…”
Get full text

History of prostate cancer treatment by Sriprasad, Seshadri, Feneley, Mark R, Thompson, Peter M

“…Abstract The last two decades have seen great advancements in our understanding of the prostate anatomy and approach including laparoscopic and robotic…”
Get full text

Surgery Illustrated: Focus on Details Photodynamic diagnostic cystoscopy by ROY, Ashoke, PAL, Pallavi, ARYA, Manit, PERSAD, Raj, KELLY, John D, FENELEY, Mark R

Get full text

Photodynamic diagnostic cystoscopy by Roy, Ashoke, Pal, Pallavi, Arya, Manit, Persad, Raj, Kelly, John D., Feneley, Mark R.

Get full text

International web survey shows high prevalence of symptomatic testosterone deficiency in men by Trinick, Tom R, Feneley, Mark R, Welford, Hugh, Carruthers, Malcolm

“…Though the clinical significance of testosterone deficiency is becoming increasingly apparent, its prevalence in the general population remains unrecognised. A…”
Get more information

The clinical significance and therapeutic implications of extraprostatic invasion by Foley, Charlotte L, Feneley, Mark R

“…Abstract Invasion of the prostatic margin by cancer establishes a higher risk of disease progression and treatment failure depending upon its extent and other…”
Get full text

Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma by Kalsi, Jas, Harland, Stephen J, Feneley, Mark R

“…This article reviews the use and application of electromotive drug administration for the intravesical treatment of bladder cancer. Strong evidence supports…”
Get more information

PROSTATE‐SPECIFIC ANTIGEN TESTING IN HYPOGONADISM: IMPLICATIONS FOR THE SAFETY OF TESTOSTERONE‐REPLACEMENT THERAPY by GOULD, DUNCAN C., FENELEY, MARK R., KIRBY, ROGER S.

“…Hypogonadal men have lower prostate volumes and serum prostate‐specific antigen (PSA) levels than age‐matched controls. When present, prostate cancer in…”
Get full text

Comparison of the zones of the human prostate with the seminal vesicle: Morphology, immunohistochemistry, and cell kinetics by Laczkó, István, Hudson, David L., Freeman, Alex, Feneley, Mark R., Masters, John R.

“…Background The prostate contains three glandular zones (central, peripheral, transition) with widely differing susceptibilities to cancer and benign prostatic…”
Get full text

Bladder-sparing strategies for transitional cell carcinoma by FENELEY, Mark R, SCHOENBERG, Mark

Get full text

The vascular response to photodynamic therapy with ATX-S10Na(II) in the normal rat colon by Harada, Masahiko, Woodhams, Josephine, MacRobert, Alexander J., Feneley, Mark R., Kato, Harubumi, Bown, Stephen G.

“…The mechanism of tissue damage from photodynamic therapy (PDT) may be cellular, vascular or both, depending on the photosensitising agent and the treatment…”
Get full text

Management of Non-muscle Invasive Bladder Cancer: A Comprehensive Analysis of Guidelines from the United States, Europe and Asia by Tan, Wei Shen, Rodney, Simon, Lamb, Benjamin, Feneley, Mark, Kelly, John

“…Highlights • All guidelines have minor variation on upper tract imaging and endoscopic treatment. • Surveillance recommendations in low-risk patients vary…”
Get full text

Today men with prostate cancer have larger prostates by Feneley, Mark R, Landis, Patricia, Simon, Inpakala, Metter, E.Jeffrey, Morrell, Christopher H, Carter, H.Ballentine, Walsh, Patrick C

“…Objectives. To examine the relationship between prostate size and the method of cancer detection in men with organ-confined prostate cancer, and compare…”
Get full text

Diagnosis of localized prostate cancer: 10 years of progress by Feneley, Mark R, Partin, Alan W

“…Advances in the diagnosis of early stage disease, and particularly the introduction of prostate-specific antigen (PSA) testing, have had a dramatic effect on…”
Get full text